Processing and presentation of antigens by dendritic cells: implications for vaccines (Q34351438)

1 August 2017

1 reference

title

Processing and presentation of antigens by dendritic cells: implications for vaccines (English)

1 reference

1 August 2017

1 reference

Bhardwaj N

1

1 reference

1 August 2017

1 September 2001

1 reference

Trends in Molecular Medicine

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

9

1 reference

1 August 2017

388-394

1 reference

Fully mobilizing host defense: building better vaccines

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Mobilizing dendritic cells for tolerance, priming, and chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Transport of peptide-MHC class II complexes in developing dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells resurrect antigens from dead cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

The makings of a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Dendritic cells injected via different routes induce immunity in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902101-3

7 January 2021

10.1016/S1471-4914(01)02101-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11530333